Cingulate Inc. Common Stock
CING
CING: Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
moreShow CING Financials
Recent trades of CING by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CING's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CING's company Twitter account
Number of mentions of CING in WallStreetBets Daily Discussion
Recent insights relating to CING
Recent picks made for CING stock on CNBC
ETFs with the largest estimated holdings in CING
Flights by private jets registered to CING